IFNGamma Priming Protects Fetal and Embryonic MSC from NK Cell-Mediated Killing and Improves their Immunosuppressive Properties: Role of Activating and Inhibitory Receptors

Giuliani M^1*, Poggi A², Bennaceur Griscelli A^3,4,5 and Lataillade JJ¹

¹Research and Cell Therapy Department, Military Blood Trasfusion Centre (CTSA), Percy Military Hospital, Clamart, France

²Molecular Oncology and Angiogenesis Unit, Oncologic Integrated Therapies, IRCCS AOU San Martino-IST National Institute for Cancer Research Genoa, Italy

³UMR 935 INSERM, Human ES Core Facility, ES Team Paris Sud, Villejuif, France

⁴University of Paris-Sud, 11, Faculty of Medicine Kremlin Bicêtre, France

⁵Division of Onco-Hematology, Paul Brousse Hospital, APHP Villejuif, France

^*Corresponding Author: Giuliani M, Military Blood Trasfusion Centre (CTSA)-Percy Military Hospital, Clamart, France, Tel: +33141467272 Email: